EP2914254
SAMSETTAR MEÐFERÐIR TIL AÐ MEÐHÖNDLA LYFJAÓNÆM KRABBAMEIN
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
30.10.2013EP published:
8.1.2020EP application number:
13851971.5
EP translation filed:
30.3.2020Grant published:
15.6.2020EPO information:
European Patent Register
Max expiry date:
29.10.2033Expiry date:
29.10.2022
Title:
COMBINATION THERAPIES TO TREAT CHEMORESISTANT CANCERS
Timeline
Today
30.10.2013EP application
8.1.2020EP Publication
30.3.2020Translation submitted
15.6.2020Registration published
29.10.2022Expires
Owner
Name:
MEI Pharma, Inc.Address:
11975 El Camino Real, Suite 101, San Diego, CA 92130, US
Inventor
Name:
GOLD, Daniel, P.Address:
San Diego, CA 92130, US
Name:
GARCIA-MANERO, GuillermoAddress:
Houston, TX 77030, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
201261720346 PDate:
30.10.2012Country:
US
Classification
Categories:
A61K 31/706, A61K 31/708, A61K 31/7068, A61K 31/245, A61K 31/4184, A61K 45/06, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 1.10.2020
Expires: 29.10.2021
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 1.10.2021
Expires: 29.10.2022
Payer: Sigurjónsson & Thor ehf.